Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 22-26 , 15 January 2008

Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease

  • Michio Kitayama

      Affiliations

    • Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan
    • Division of Legal Medicine, Department of Social Medicine, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan
    • Corresponding Author InformationCorresponding author. Department of Neurology, Institute of Neurological Sciences Faculty of Medicine, Tottori University 36-1 Nishi-cho, Yonago, 683-8504, Japan. Tel.: +81 859 38 6757; fax: +81 859 38 6759.
    • ,
  • Kenji Wada-Isoe

      Affiliations

    • Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan
    • ,
  • Yoshito Irizawa

      Affiliations

    • Division of Legal Medicine, Department of Social Medicine, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Japan
    • ,
  • Kenji Nakashima

      Affiliations

    • Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan

Received 3 April 2007 ,Revised 10 July 2007 ,Accepted 11 July 2007.

References 

  1. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22–31
  2. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67:189–194
  3. Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology. 2006;66:1850–1854
  4. Orimo S, Amino T, Takahashi A, Kojo T, Uchihara T, Mori F, et al. Cardiac sympathetic denervation in Lewy body disease. Parkinsonism Relat Disord. 2006;12(Suppl 2):S99–S105
  5. Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005;76:249–251
  6. Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, et al. Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003;74:423–426
  7. Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci. 2004;220:105–111
  8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
  9. American Psychiatric Association. In: fourth edition. Diagnostic and statistical manual of mental disorders. Washington DC, USA: American Psychiatric Association; 1994;p. 133–155
  10. Poewe W. Psychosis in Parkinson's disease. Mov Disord. 2003;18:S80–S87
  11. Williams DR, Lees AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol. 2005;4:605–610
  12. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord. 2005;20:130–140
  13. Fenelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology. 2006;66:93–98
  14. Pacchetti C, Manni R, Zangaglia R, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord. 2005;20:1439–1448
  15. Papapetropoulos S, Argyriou A, Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol. 2005;252:1223–1228
  16. Hietanen M, Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:244–249
  17. Martin WE, Loewenson RB, Resch JA. Parkinson's disease. Clinical analysis of 100 patients. Neurology. 1973;23:783–790
  18. Aarsland D, Zaccai J, Brayne CA. Systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 2005;20:1255–1263
  19. Aarsland D, Larsen JP, Cummins JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol. 1999;56:595–601
  20. Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 2000;123:733–745
  21. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001;70:734–738
  22. Mantysaari M, Kuikka J, Mustonen J, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using 123I-metaiodobenzylguanidine. Diabetes. 1992;41:1069–1075
  23. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123 metaiodobenzylguanidine. J Am Coll Cardiol. 1989;14:1519–1526
  24. Sisson JC, Shapiro B, Meyers L, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625–1636
  25. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71–77
  26. Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med. 2000;27:566–573
  27. Kitayama M. Wada-Isoe K, Nakaso K, Irizawa Y, Nakashima, K. Clinical evaluation of Parkinson’s diseasae dementia: association with aging and visual hallucination. Acta Scand Neurol (in press), doi:10.1111/j.16660-0404.2007.00860.x.
  28. Druschky A, Hilz MJ, Hopp P, et al. Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [123I] metaiodobenzylguanidine-SPECT. Brain. 2001;124:2372–2382
  29. Lee PH, Yeo SH, Kim HJ, Youm HY. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord. 2006;21:1975–1977

PII: S0022-510X(07)00481-9

doi: 10.1016/j.jns.2007.07.017

Journal of the Neurological Sciences
Volume 264, Issue 1 , Pages 22-26 , 15 January 2008

Article Tools

* Image Usage & Resolution